Your browser is no longer supported. Please, upgrade your browser.
Settings
VRML Vermillion, Inc. daily Stock Chart
VRML [NASD]
Vermillion, Inc.
Index- P/E- EPS (ttm)-0.18 Insider Own1.70% Shs Outstand94.96M Perf Week-13.37%
Market Cap52.23M Forward P/E- EPS next Y- Insider Trans- Shs Float51.14M Perf Month0.00%
Income-13.50M PEG- EPS next Q- Inst Own27.20% Short Float4.52% Perf Quarter-44.45%
Sales3.60M P/S14.51 EPS this Y19.20% Inst Trans41.15% Short Ratio9.61 Perf Half Y-59.56%
Book/sh0.18 P/B3.06 EPS next Y- ROA-105.30% Target Price1.00 Perf Year-5.25%
Cash/sh0.17 P/C3.22 EPS next 5Y- ROE-159.50% 52W Range0.27 - 1.57 Perf YTD83.33%
Dividend- P/FCF- EPS past 5Y17.40% ROI-130.30% 52W High-64.97% Beta3.31
Dividend %- Quick Ratio4.90 Sales past 5Y3.50% Gross Margin14.00% 52W Low103.63% ATR0.07
Employees43 Current Ratio4.90 Sales Q/Q57.10% Oper. Margin- RSI (14)41.66 Volatility13.03% 13.03%
OptionableYes Debt/Eq0.10 EPS Q/Q-28.80% Profit Margin- Rel Volume1.08 Prev Close0.53
ShortableYes LT Debt/Eq0.09 EarningsAug 08 AMC Payout- Avg Volume240.57K Price0.55
Recom- SMA20-4.24% SMA50-15.78% SMA200-35.72% Volume258,966 Change3.75%
Mar-29-16Reiterated Canaccord Genuity Buy $4 → $2.50
Oct-25-12Upgrade Ladenburg Thalmann Sell → Neutral
Mar-07-12Downgrade Ladenburg Thalmann Neutral → Sell
Sep-16-11Initiated Ladenburg Thalmann Neutral
Sep-04-19 08:00AM  Vermillion Announces Two Independent Publications Showing OVA1® (MIA- Multivariate Index Assay) Demonstrates Improved Ovarian Malignancy Risk Detection in African-American Women Business Wire +15.92%
Sep-01-19 11:10PM  Edited Transcript of VRML earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-23-19 11:15AM  Vermillion, Inc.'s (NASDAQ:VRML) Earnings Dropped -9.7%, How Did It Fare Against The Industry? Simply Wall St.
Aug-08-19 04:05PM  Vermillion Reports Second Quarter 2019 Financial Results GlobeNewswire
Jul-31-19 04:01PM  Vermillion to Report Second Quarter 2019 Financial Results on August 8 GlobeNewswire
Jul-24-19 10:31AM  Does Vermillion, Inc.'s (NASDAQ:VRML) CEO Pay Reflect Performance? Simply Wall St.
Jul-16-19 08:00AM  Vermillion Announces Publication of New Study Demonstrating Overas Greater Sensitivity in Detecting Ovarian Cancer Compared with ROMA, HE4 + CA125, and CA125 Alone Business Wire
Jun-26-19 09:14AM  Vermillion, Inc. Announces Pricing of $15 Million Public Offering of Common Stock GlobeNewswire
07:19AM  The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart Benzinga
Jun-25-19 04:01PM  Vermillion, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire -12.86%
Jun-20-19 06:33PM  Vermillion Adds Two Major Contracted Agreements for OVA1 GlobeNewswire -13.93%
Jun-18-19 01:27PM  Who Has Been Buying Vermillion, Inc. (NASDAQ:VRML) Shares? Simply Wall St. +6.84%
May-30-19 03:32PM  Edited Transcript of VRML earnings conference call or presentation 14-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-14-19 04:28PM  Vermillion: 1Q Earnings Snapshot Associated Press
04:05PM  Vermillion Reports First Quarter 2019 Financial Results GlobeNewswire
02:30PM  Vermillion, Inc. to Host Earnings Call ACCESSWIRE
May-13-19 04:01PM  Vermillion Announces Acceptance of Publication Ethnic Disparity Data Showing OVA1® (MIA) Superiority over CA125 and HE4 in Detecting Ovarian Cancer Risk GlobeNewswire
May-10-19 12:28PM  What Kind Of Investor Owns Most Of Vermillion, Inc. (NASDAQ:VRML)? Simply Wall St. +9.02%
Apr-22-19 10:07AM  Vermillion to Report First Quarter 2019 Financial Results on May 14 GlobeNewswire
Apr-04-19 04:26AM  Edited Transcript of VRML earnings conference call or presentation 28-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Apr-03-19 03:47PM  If You Had Bought Vermillion (NASDAQ:VRML) Stock Five Years Ago, You'd Be Sitting On A 61% Loss, Today Simply Wall St. -8.11%
Apr-02-19 04:20PM  Vermillion Exhibits OVA1 Ethnic Disparity Performance Poster at the American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire
Mar-28-19 04:18PM  Vermillion: 4Q Earnings Snapshot Associated Press
04:01PM  Vermillion Reports Fourth Quarter and Year-End 2018 Financial Results GlobeNewswire
Mar-12-19 12:27PM  Vermillion to Report Fourth Quarter and Year End 2018 Financial Results on Thursday, March 28 GlobeNewswire
Jan-22-19 12:46PM  Could Vermillion, Inc.s (NASDAQ:VRML) Investor Composition Influence The Stock Price? Simply Wall St.
Jan-15-19 09:46AM  Vermillion Announces Coverage by Cigna for OVA1® (MIA) GlobeNewswire +21.96%
Dec-14-18 01:24PM  What Investors Should Know About Vermillion, Inc.s (NASDAQ:VRML) Financial Strength Simply Wall St.
Nov-21-18 07:32AM  Edited Transcript of VRML earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents +7.09%
Nov-20-18 04:01PM  Vermillion to Present at the Piper Jaffray 30th Annual Healthcare Conference GlobeNewswire
Nov-14-18 08:00AM  New Research Coverage Highlights Nexa Resources S.A, Qumu, Clearway Energy, Vermillion, Cantel Medical, and Theravance Biopharma Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire -7.19%
Nov-12-18 08:00AM  Vermillion to Present at the Canaccord Medical Technology & Diagnostics Forum GlobeNewswire -12.23%
Nov-09-18 12:16PM  Is Vermillion Incs (NASDAQ:VRML) CEO Salary Justified? Simply Wall St.
Nov-08-18 05:12PM  Vermillion: 3Q Earnings Snapshot Associated Press
04:01PM  Vermillion Reports Third Quarter 2018 Financial Results GlobeNewswire
04:01PM  Vermillion Announces OVA1® (MIA) and OVERA® (MIA2G) Study and Coverage by Clalit Health Services in Israel GlobeNewswire
Oct-26-18 04:05PM  Vermillion to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Thursday, November 8 GlobeNewswire +8.65%
Oct-09-18 08:00AM  Vermillion, Inc. Announces the Launch of OVA1®+ GlobeNewswire -9.27%
Sep-06-18 09:00AM  Vermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell GlobeNewswire
Aug-28-18 02:21PM  Edited Transcript of VRML earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents +5.86%
Aug-21-18 04:01PM  Vermillion, Inc. Appoints Nancy Cocozza to its Board of Directors GlobeNewswire
Aug-09-18 05:07PM  Vermillion: 2Q Earnings Snapshot Associated Press
04:01PM  Vermillion Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-18-18 08:00AM  Vermillion to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Thursday, August 9 GlobeNewswire +22.39%
Jun-26-18 11:56AM  Analysts Expect Breakeven For Vermillion Inc (NASDAQ:VRML) Simply Wall St. +10.54%
Jun-13-18 11:08AM  Vermillion Names Chris Goulart to Senior Vice President of Commercial Operations GlobeNewswire -5.88%
Jun-04-18 08:58PM  At $1, Is Vermillion Inc (NASDAQ:VRML) A Buy? Simply Wall St. -8.37%
May-22-18 01:53PM  Edited Transcript of VRML earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-14-18 04:44PM  Vermillion: 1Q Earnings Snapshot Associated Press
04:01PM  Vermillion Reports First Quarter 2017 Financial Results GlobeNewswire
12:45PM  Vermillion, Inc. to Host Earnings Call ACCESSWIRE
May-03-18 04:01PM  Vermillion to Report First Quarter 2018 Financial Results on Monday, May 14 GlobeNewswire
Apr-26-18 08:00AM  Vermillion Announces Recognition by and Publication in Two Top Physician Educational Resources GlobeNewswire
Apr-13-18 09:17AM  Vermillion, Inc. Announces Pricing of $15 Million Concurrent Public Offerings of Common Stock and Preferred Stock GlobeNewswire -14.71%
Apr-12-18 04:44PM  Vermillion, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock GlobeNewswire
Apr-04-18 12:31PM  Vermillion Inc (NASDAQ:VRML): Immense Growth Potential? Simply Wall St.
Mar-23-18 02:28PM  Did Vermillion Incs (NASDAQ:VRML) Recent Earnings Growth Beat The Trend? Simply Wall St.
Mar-14-18 01:16PM  Edited Transcript of VRML earnings conference call or presentation 13-Mar-18 8:30pm GMT Thomson Reuters StreetEvents
Mar-13-18 04:19PM  Vermillion reports 4Q loss Associated Press
04:01PM  Vermillion Reports Fourth Quarter and Fiscal Year 2017 Financial Results GlobeNewswire
12:00PM  Vermillion, Inc. to Host Earnings Call ACCESSWIRE
Mar-07-18 04:01PM  Vermillion to Present at the 30th Annual ROTH Conference GlobeNewswire
Feb-28-18 08:00AM  Vermillion to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, March 13 GlobeNewswire +7.14%
Feb-23-18 08:00AM  Vermillion to Present at the 2018 BTIG Healthcare Conference GlobeNewswire
Feb-19-18 06:11PM  What Is Vermillion Incs (NASDAQ:VRML) Share Price Doing? Simply Wall St.
Feb-05-18 08:45AM  Vermillion Announces the Grant of Two Ovarian Cancer Diagnostic Patents PR Newswire
Jan-18-18 08:45AM  Vermillion Announces Agreement with BlueCross BlueShield of Illinois PR Newswire
Jan-01-18 09:13AM  Vermillion, Inc. :VRML-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018 Capital Cube
Dec-26-17 07:05PM  Are Vermillion Incs (NASDAQ:VRML) Interest Costs Too High? Simply Wall St.
Dec-19-17 08:45AM  Vermillion Appoints Bob Beechey to Newly Created CFO Post PR Newswire
Nov-21-17 08:45AM  Vermillion to Present at the 29th Annual Piper Jaffray Healthcare Conference PR Newswire
Nov-20-17 08:56AM  ASPiRA Labs Announces Release of Final CMS Reimbursement Rate for OVA1 PR Newswire +18.27%
Nov-16-17 08:45AM  Vermillion Announces Publication of Foundational Health Economics Study PR Newswire
Nov-12-17 03:39AM  Edited Transcript of VRML earnings conference call or presentation 8-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-08-17 04:46PM  Vermillion reports 3Q loss Associated Press
04:01PM  Vermillion Reports Third Quarter 2017 Results PR Newswire
12:30PM  Vermillion, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-17 03:30PM  Vermillion to Present at the Canaccord Genuity 2017 Medical Technologies & Diagnostics Forum PR Newswire
Nov-01-17 08:45AM  ASPiRA Labs Announces a Major Coverage Milestone - A 27% Increase in Covered Lives for OVA1 PR Newswire +23.18%
Oct-31-17 08:45AM  ASPiRA Labs Announces OVA1 Contract with Louisiana Blue Cross Blue Shield PR Newswire
Oct-27-17 08:45AM  ASPiRA Labs Lands Strategic Managed Care Coverage and Medicaid Licensure for OVA1® PR Newswire
Oct-25-17 04:01PM  Vermillion to Report Third Quarter 2017 Financial Results and Host Investor Conference Call on November 8th PR Newswire -5.67%
Oct-02-17 04:45PM  ASPiRA Labs Announces In-Network Contract Agreement with HealthNet Federal Services for OVA1® PR Newswire -8.33%
11:11AM  ETFs with exposure to Vermillion, Inc. : October 2, 2017 Capital Cube
Sep-20-17 04:27PM  Is It Too Late To Buy Vermillion Inc (VRML)? Simply Wall St.
Sep-19-17 06:49PM  ETFs with exposure to Vermillion, Inc. : September 19, 2017 Capital Cube
Sep-18-17 01:09PM  Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017 Capital Cube
Aug-31-17 02:00PM  Vermillion and ASPiRA Labs Kick Off Ovarian Cancer Awareness Month with 100,000th Patient Test Milestone and Ringing the Nasdaq Opening Bell PR Newswire
10:00AM  Vermillion, Inc. (Nasdaq: VRML) to Ring The Nasdaq Stock Market Opening Bell for Ovarian Cancer Awareness Month GlobeNewswire
Aug-15-17 10:15PM  Edited Transcript of VRML earnings conference call or presentation 9-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-17 04:46PM  Vermillion reports 2Q loss Associated Press
04:01PM  Vermillion Reports Second Quarter 2017 Results PR Newswire
Aug-08-17 10:20AM  Investor Network: Vermillion, Inc. to Host Earnings Call ACCESSWIRE
Aug-04-17 12:45PM  Vermillion Announces Date Change of Second Quarter 2017 Financial Results and Investor Conference Call PR Newswire
Aug-01-17 04:01PM  Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th PR Newswire
Jul-27-17 04:01PM  Vermillion to Report Second Quarter 2017 Financial Results and Host Investor Conference Call on August 8th PR Newswire
Jul-11-17 03:10PM  ETFs with exposure to Vermillion, Inc. : July 11, 2017 Capital Cube
May-19-17 07:05PM  Edited Transcript of VRML earnings conference call or presentation 11-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-15-17 04:54PM  ETFs with exposure to Vermillion, Inc. : May 15, 2017 Capital Cube
May-12-17 11:40AM  Vermillion, Inc. :VRML-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schuler Henri George10% OwnerJun 28Buy0.804,750,0003,800,0006,047,057Jul 02 04:37 PM
SCHULER JACK W10% OwnerJun 28Buy0.805,000,0004,000,00022,378,242Jul 02 04:36 PM
Palmieri Valerie BarberPresident and CEOJun 28Buy0.8037,50030,000215,563Jul 01 04:32 PM
SCHREIBER DAVIDDirectorJun 03Sale1.1010,00011,000164,905Jun 04 07:07 PM
Beechey Robert HarryChief Financial OfficerMay 17Buy1.265,0006,292205,000May 17 12:26 PM
SCHREIBER DAVIDDirectorMar 07Sale1.0030,00030,000137,405Mar 11 04:20 PM
Beechey Robert HarryChief Financial OfficerDec 06Buy0.5725,00014,250200,000Dec 06 04:23 PM